There has been minimal news coverage of a congressional committee hearing that was held yesterday on a surveillance operation the Food and Drug Administration (FDA) conducted against five employees who were making whistleblower complaints and yet the nature of what the FDA did exemplifies a key problem with government agencies currently. Administrators of agencies or [...]
|By: Kevin Gosztola Thursday February 27, 2014 2:01 pm|
|By: Kevin Gosztola Wednesday February 26, 2014 11:51 am|
A congressional investigation into a surveillance program by the Food and Drug Administration (FDA), which was “unprecedented in scope and intensity” and directed at whistleblowers working within the agency, concluded that the spying operation was unlawful. House Oversight and Government Reform Committee Chairman Darrell Issa and Senate Judiciary Committee Ranking Member Chuck Grassley released a [...]
|By: Jeff Kaye Saturday August 20, 2011 6:53 pm|
On August 18, Senator Dianne Feinstein put out a press release indicating that the Department of Defense should consider taking the anti-malarial drug mefloquine, also known as Lariam, out of the DoD drug formulary as it is too dangerous. Feinstein also indicated the drug has been administered to military personnel without the safeguards put in place by a 2009 Department of Defense protocol. But the drug was also used in massive doses on all the Guantanamo detainees, an unprecedented application of the drug on prisoners for supposed preventative purposes.